BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37735654)

  • 1. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care.
    Syed U; Subramanian A; Wraith DC; Lord JM; McGee K; Ghokale K; Nirantharakumar K; Haroon S
    BMC Med; 2023 Sep; 21(1):363. PubMed ID: 37735654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing.
    Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
    Arthritis Care Res (Hoboken); 2023 Feb; 75(2):317-325. PubMed ID: 34486829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
    Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
    Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease.
    Braithwaite T; Adderley NJ; Subramanian A; Galloway J; Kempen JH; Gokhale K; Cope AP; Dick AD; Nirantharakumar K; Denniston AK
    Arthritis Rheumatol; 2021 Jul; 73(7):1267-1276. PubMed ID: 33728815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms and risk factors for long COVID in non-hospitalized adults.
    Subramanian A; Nirantharakumar K; Hughes S; Myles P; Williams T; Gokhale KM; Taverner T; Chandan JS; Brown K; Simms-Williams N; Shah AD; Singh M; Kidy F; Okoth K; Hotham R; Bashir N; Cockburn N; Lee SI; Turner GM; Gkoutos GV; Aiyegbusi OL; McMullan C; Denniston AK; Sapey E; Lord JM; Wraith DC; Leggett E; Iles C; Marshall T; Price MJ; Marwaha S; Davies EH; Jackson LJ; Matthews KL; Camaradou J; Calvert M; Haroon S
    Nat Med; 2022 Aug; 28(8):1706-1714. PubMed ID: 35879616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
    Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
    JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study.
    Belleudi V; Rosa AC; Poggi FR; Armuzzi A; Nicastri E; Goletti D; Diamanti AP; Davoli M; Agabiti N; Addis A
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34071452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
    Conrad N; Misra S; Verbakel JY; Verbeke G; Molenberghs G; Taylor PN; Mason J; Sattar N; McMurray JJV; McInnes IB; Khunti K; Cambridge G
    Lancet; 2023 Jun; 401(10391):1878-1890. PubMed ID: 37156255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases.
    Khan R; Kuenzig ME; Tang F; Im JHB; Widdifield J; McCurdy JD; Kaplan GG; Benchimol EI
    JAMA Netw Open; 2023 Oct; 6(10):e2337020. PubMed ID: 37812417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong.
    Lui DTW; Xiong X; Cheung CL; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Chung MSH; Au ICH; Lee CH; Ip TP; Woo YC; Tan KCB; Wong CKH; Wong ICK
    J Bone Miner Res; 2024 May; 39(5):551-560. PubMed ID: 38477768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
    PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of immunosuppressive therapy on SARS-CoV-2 mRNA vaccine effectiveness in patients with immune-mediated inflammatory diseases: a Danish nationwide cohort study.
    Elmahdi R; Ward D; Ernst MT; Poulsen G; Hallas J; Pottegård A; Jess T
    BMJ Open; 2024 Feb; 14(2):e077408. PubMed ID: 38387988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
    Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
    BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study.
    Chang R; Yen-Ting Chen T; Wang SI; Hung YM; Chen HY; Wei CJ
    EClinicalMedicine; 2023 Feb; 56():101783. PubMed ID: 36643619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID study.
    Geldof J; Truyens M; Sabino J; Ferrante M; Lambert J; Lapeere H; Hillary T; Van Laethem A; de Vlam K; Verschueren P; Padalko E; Lobaton T; Vermeire S
    Front Immunol; 2023; 14():1126351. PubMed ID: 36936974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
    Sarmiento-Monroy JC; Espinosa G; Londoño MC; Meira F; Caballol B; Llufriu S; Carrasco JL; Moll-Udina A; Quintana LF; Giavedoni P; Ramírez J; Inciarte-Mundo J; Solana E; Blanco Y; Martinez-Hernandez E; Sepúlveda M; Llorenç V; Prieto-González S; Espígol-Frigolé G; Milisenda JC; Cid MC; Mascaró JM; Blanco I; Barberá JA; Sibila O; Gratacos-Ginès J; Adán A; Agustí A; Sanmartí R; Panés J; Cervera R; Vila J; Soriano A; Gómez-Puerta JA;
    J Autoimmun; 2021 Feb; 117():102580. PubMed ID: 33338707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
    J Rheumatol; 2022 May; 49(5):523-530. PubMed ID: 35105713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
    Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
    Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.